Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
10/21/2009 | EP2109480A2 Use of antagonists of the interaction between hiv gp120 and alpha4beta7 integrin |
10/21/2009 | EP2109459A1 Archaeal polar lipid aggregates for administration to animals |
10/21/2009 | EP2109455A2 Compositions and methods for stimulating an immune response |
10/21/2009 | EP1853582B1 Heterocyclylamide-substituted imidazoles |
10/21/2009 | EP1513531B1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
10/21/2009 | EP1492785B9 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors |
10/21/2009 | EP1450750B1 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
10/21/2009 | EP1423413B1 Peptidic compounds selectively binding to p-selectin |
10/21/2009 | EP1383778B1 Agonists and antagonists of sphingosine-1-phosphate receptors |
10/21/2009 | EP1381366B9 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
10/21/2009 | EP1371373B1 Recombination super compound interferon used as hepatitis b surface antigen and e antigen inhibitor |
10/21/2009 | EP1164991B1 Gels formed by the interaction of poly(aldehyde) with various substances |
10/21/2009 | EP1109576B1 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide |
10/21/2009 | EP1047784B1 Neissera meningitidis antigens |
10/21/2009 | CN101563362A Recombinant HCV E2 glycoprotein |
10/21/2009 | CN101563353A Antibacterial compounds and processes for its production |
10/21/2009 | CN101563352A Antiviral indoles |
10/21/2009 | CN101563341A Piperidine derivative used for treating chemokine receptor 5 mediated diseases |
10/21/2009 | CN101563100A Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
10/21/2009 | CN101563099A Use of beta-lactamase |
10/21/2009 | CN101563093A Grifola frondosa-origin substance having antiinfluenza virus activity and method of producing the same |
10/21/2009 | CN101563084A 4-(1-amino-ethyl)-cyclohexylamine derivatives |
10/21/2009 | CN101560520A Japanese encephalitis/dengue chimeric virus and application thereof |
10/21/2009 | CN101560503A Influenza A virus Vero cell adapted strain and application thereof |
10/21/2009 | CN101560246A Thymopentin derivate, preparation method and application of derivate and compound containing derivate in preparing drugs |
10/21/2009 | CN101560245A CTL epitope polypeptide of avian influenza H5N1 virus and application thereof |
10/21/2009 | CN101560236A Method for synthesizing marine polyhydroxyl sterol (25R)-5alpha -cholest-3 beta, 5alpha, 6beta, 26-tetrol |
10/21/2009 | CN101560216A Method for preparing cefditoren pivoxil |
10/21/2009 | CN101560209A Oxazolidinone compound containing pyridine and preparation method thereof |
10/21/2009 | CN101560198A New isoandrographolidume sulfonate, pharmaceutical composition containing sulfonate, preparation method and applications thereof |
10/21/2009 | CN101560193A Alpha-polyhalide acetyl piperazinyl oxazolidone compound and antibacterium application thereof |
10/21/2009 | CN101560189A Metronidazole and compound for substituting salicylic acid and preparation method and application thereof |
10/21/2009 | CN101559226A Drug component for preventing and curing pig diarrhea |
10/21/2009 | CN101559225A Meningococcus vaccine |
10/21/2009 | CN101559224A Poliomyelitis vaccine |
10/21/2009 | CN101559223A Idemic encephalitis diphtheria-pertussis-tetanus combined vaccine |
10/21/2009 | CN101559222A Combined vaccine bonding bacterial polysaccharides and protein for human |
10/21/2009 | CN101559221A Binuclear protein reverse transcription colony vaccine against H1N1 influenza A |
10/21/2009 | CN101559202A Zedoary turmeric oil adhesive membrane for external application and preparation method thereof |
10/21/2009 | CN101559188A Traditional Chinese medicine compound preparation used for treating colpitis and tinea manus and pedis and preparation method thereof |
10/21/2009 | CN101559186A Pharmaceutical composition for treating pulmonary tuberculosis, pneumonia and bronchitis |
10/21/2009 | CN101559170A Epidemics clearing and sore-throat relieving tea |
10/21/2009 | CN101559150A Traditional Chinese medicine preparation for treating hepatitis B |
10/21/2009 | CN101559140A Micelle solution for immune regulation |
10/21/2009 | CN101559138A Externally applied medicament for treating porcine foot-and-mouth disease and PRRS |
10/21/2009 | CN101559136A Combined medicament for treating tinea corporis and tinea manus and pedis and preparation method thereof |
10/21/2009 | CN101559108A Chinese medicinal preparation for treating beriberi, tinea corporis, tinea cruris and method for preparing same |
10/21/2009 | CN101559107A Chinese materia medica preparation for treating folliculitis |
10/21/2009 | CN101559105A Composite for curing viral diseases of birds and preparation method thereof |
10/21/2009 | CN101559103A Sterilizing and itching-relieving medical composition |
10/21/2009 | CN101559099A Traditional Chinese medicine composition for curing wind cold and preparation method thereof |
10/21/2009 | CN101559096A Verruca-eliminating liquid medicine and preparation method thereof |
10/21/2009 | CN101559088A Production technique of andrographolide and neoandrographolide, dehydroanddrographolide, oxyandrographolide |
10/21/2009 | CN101559087A New technique for preparing extract of Syringa amurensis Rupr bark and new applications thereof |
10/21/2009 | CN101559068A Novel application of azidothymidine in treating leukaemia |
10/21/2009 | CN101559063A External medicament for curing herpes zoster and preparation method thereof |
10/21/2009 | CN101559061A Pharmaceutical composition and injection for treating unknown high fever of pigs and preparation method thereof |
10/21/2009 | CN101559040A Medicament composition of cefotiam hydrochloride and preparation thereof |
10/21/2009 | CN101559021A Disposable vaginal lotion |
10/21/2009 | CN101558877A Teabag containing paeoniifolia for clearing heat, reducing pathogenic fire, resisting bacterium and diminishing inflammation and manufacturing method thereof |
10/21/2009 | CN100552016C Bifidobacterium in treatment of inflammatory disease |
10/21/2009 | CN100551931C T cell receptor display |
10/21/2009 | CN100551928C M-crystal type of adefovir dipivoxil ester and preparation method and medicine application |
10/21/2009 | CN100551916C Novel 2,4-diamino-1,3,5-triazine derivative |
10/21/2009 | CN100551443C Nano carbon tube infusion agent preparation method |
10/21/2009 | CN100551441C Compositions comprising neisseria meningitidis sero-group B and C and other antigen |
10/21/2009 | CN100551436C Anti-hepatitis B virus ascidians polypeptide medicine composition and the preparing method |
10/21/2009 | CN100551420C Externally used Chinese traditional medicine emulsion preparations having antibiotic effect and method for preparing the same |
10/21/2009 | CN100551417C Food antibiotic and its preparation process |
10/21/2009 | CN100551385C Externally used traditional Chinese medicine and its preparing process |
10/21/2009 | CN100551378C Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac |
10/21/2009 | CN100551376C Antibiotic slow-release preparation for local use |
10/21/2009 | CN100551375C Use of 23-hydroxy betutic acid in preparing medicine for treating and preventing glioma |
10/21/2009 | CN100551368C Ciclopirox olamine gelling agent, method for preparing the same and pharmaceutical use thereof |
10/21/2009 | CN100551367C Use of chloride 13-hexyl berberine and chloride 13-hexyl palmatine in preparation of medicine for treating vagina infection-inflammation |
10/21/2009 | CN100551366C Use of atractylone in preparing influenza virus resisting medicine |
10/21/2009 | CN100551362C Shuanghuanglian effervescence tablet and preparation thereof |
10/21/2009 | CN100551361C Defervesce effervescence tablet for treating cold and preparation method thereof |
10/21/2009 | CN100551360C Radix Isatidis effervescence tablet and preparation method thereof |
10/20/2009 | US7605261 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
10/20/2009 | US7605183 Using 4,4-dimethyl-6-methylene-2-cyclohexen -1-one |
10/20/2009 | US7605179 administering vitamin k derivatives for prophylaxis of neurodegenerative diseases associated with protein aggregation or neurofibrillary tangles |
10/20/2009 | US7605157 Tricyclic tetrahydroquinoline antibacterial agents |
10/20/2009 | US7605147 Acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same |
10/20/2009 | US7604810 Conserved Neisserial antigens |
10/20/2009 | US7604809 Reinforcing systemic immune responses with lactobacillus casei |
10/20/2009 | US7604803 Codelivery to a cell of nucleic acid and assistor protein (antigen) where the nucleic acid encodes an antigenic protein or which shares an epitope(s) with the assistor protein; the nucleic acid is entrapped in liposome intravesicular space; assistor protein is on the liposome surface; synergistic |
10/20/2009 | CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection |
10/20/2009 | CA2540279C Hiv vaccine composition |
10/20/2009 | CA2450122C Novel heterocyclic antibacterial compounds |
10/20/2009 | CA2446712C System for osmotic delivery of pharmaceutically active agents |
10/20/2009 | CA2408142C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
10/20/2009 | CA2402267C Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails |
10/20/2009 | CA2393303C Meglumine salt of a specific quinolinecarboxylic acid compound |
10/20/2009 | CA2378183C Antibacterial heterobicyclic substituted phenyl oxazolidinones |
10/20/2009 | CA2376894C Pharmaceutical composition comprising a protein and an ectoine |
10/20/2009 | CA2164717C Method of combatting hepatitis b virus infection |
10/15/2009 | WO2009126912A1 Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections |
10/15/2009 | WO2009126726A1 Methods and compositions for diagnosing and modulating human papillomavirus (hpv) |
10/15/2009 | WO2009126515A1 Compounds and compositions as protein kinase inhibitors |